03.01.07
Zylera Pharmaceuticals, Research Triangle Park, NC, has launched Re-lamine (chondroitin 300 mg, glucosamine 400 mg and primorine 425 mg), a novel prescription treatment for osteoarthritis. Zylera says Re-lamine is the first and only prescription product that contains pharmaceutical quality glucosamine, chondroitin and primorine. It helps reduce the pain and inflammation associated with osteoarthritis, while also slowing the onset and progression of osteo-arthritis.